MMSI - Merit Medical Systems, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Merit Medical Systems, Inc.

1600 West Merit Parkway
South Jordan, UT 84095
United States
801-253-1600
http://www.merit.com

SectorHealthcare
IndustryMedical Instruments & Supplies
Full Time Employees6,355

Key Executives

NameTitlePayExercisedYear Born
Mr. Fred P. LampropoulosChairman, CEO & Pres3.09M4.59M1950
Mr. Raul Parra Jr., CPACFO & Treasurer866.81k96.11k1979
Mr. Ronald A. FrostChief Operating Officer748.19k481.64k1962
Mr. Brian G. LloydChief Legal Officer & Corp. Sec.810.25kN/A1961
Mr. Joseph C. WrightPres of International Division861.84k715.16k1970
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology, critical care, and endoscopy. It operates in Cardiovascular and Endoscopy segments. It provides peripheral intervention products for diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, hemostasis, intervention, interventional fluid management, pressure monitoring, and cardiac rhythm management, as well as thermodilution and pulmonary artery catheters and electrophysiology to treat various heart conditions. It also offers cardiovascular and critical care products to treat patients with life-threatening diseases, and protect healthcare providers from exposure to bloodborne pathogens. In addition, it provides interventional oncology and spine products to treat metastatic spinal tumors, liver cancer, uterine fibroids, benign prostatic hyperplasia, vertebral compression fractures, and arteriovenous malformations and hemostatic embolization, as well as breast cancer localization and guidance products for the treatment of breast cancer. Further, the company offers non-vascular stents to treat pulmonary and gastrointestinal diseases; dilation balloons to endoscopically dilate strictures; and kits and accessories for endoscopy and bronchoscopy procedures. Additionally, it provides coated tubes and wires; microelectromechanical system sensor components; ConvertX nephroureteral stent system; and Fibrovein. The company sells its products to hospitals and clinic-based physicians, technicians, and nurses through its direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was founded in 1987 and is headquartered in South Jordan, Utah.

Corporate Governance

Merit Medical Systems, Inc.’s ISS Governance QualityScore as of December 3, 2019 is 3. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 5; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.